Organization: Health Canada
Year: 2020
Month: April
Request Number: A-2019-000441
Request Summary: Any correspondence between Health Canada and any representative of Purdue Pharmaceutical in regards to any deceptive or manipulative marketing practices by the company in the sales of any of its products, in particular, of OyxContin by Purdue Pharmaceutical to Canadians.
Disposition: Disclosed in part
Number of pages: 31